Table 1 Baseline characteristics of patients by tertiles of stress hyperglycemia ratio
Characteristics | Total (n=487) | Tertile 1 (n=162) | Tertile 2 (n=162) | Tertile 3 (n=163) | P |
|---|---|---|---|---|---|
Age, mean (SD) | 83.0 (5.9) | 82.8 (5.6) | 83.0 (5.9) | 83.3 (6.2) | 0.81 |
Male, n (%) | 351 (72.0) | 118 (72.8) | 107 (66.0) | 126 (77.3) | 0.08 |
BMI, kg/m2, mean (SD) | 22.8 (3.5) | 22.5 (3.1) | 23.2 (3.9) | 22.9 (3.6) | 0.17 |
Married, n (%) | 405 (83.2) | 142 (87.7) | 133 (82.1) | 130 (79.8) | 0.15 |
High school and above, n (%) | 337 (69.2) | 112 (69.2) | 110 (67.9) | 115 (70.5) | 0.92 |
Smoker, n (%) | 180 (37.0) | 59 (36.4) | 50 (30.9) | 71 (43.6) | 0.06 |
Drinker, n (%) | 99 (20.3) | 27 (16.7) | 34 (21.0) | 38 (23.3) | 0.32 |
Diabetes mellitus, n (%) | 184 (37.8) | 60 (37.0) | 57 (35.2) | 67 (41.1) | 0.53 |
Emergency admission, n (%) | 51 (10.5) | 14 (8.6) | 10 (6.2) | 27 (16.6) | 0.01 |
Blood glucose, mmol/L, mean (SD) | 6.7 (3.0) | 5.1 (1.2) | 6.2 (1.6) | 8.8 (3.9) | <0.001 |
Hypoglycemia, n (%) | 8 (1.6) | 8 (4.9) | 0 (0.0) | 0 (0.0) | <0.001 |
Hyperglycemia, n (%) | 93(19.1) | 5 (3.1) | 20 (12.3) | 68 (41.7) | <0.001 |
HbA1c, %, mean (SD) | 6.4 (1.2) | 6.5 (1.3) | 6.4 (1.2) | 6.4 (1.2) | 0.51 |
SHR, median (IQR) | 0.81 (0.72-0.96) | 0.69 (0.64-0.72) | 0.81 (0.78-0.85) | 1.05 (0.96-1.22) | <0.001 |
WBC, ×109/L, mean (SD) | 6.7 (2.7) | 6.3 (2.0) | 6.5 (2.9) | 7.3 (3.0) | 0.004 |
BUN, mmol/l, mean (SD) | 7.8 (5.7) | 6.9 (3.4) | 6.9 (4.2) | 9.5 (8.1) | <0.001 |
Creatinine, umol/L, median (IQR) | 82.0 (66.8-100.0) | 78.5 (66.6-94.0) | 78.0 (64.0-93.3) | 89.0 (71.0-117.9) | 0.001 |
Albumin, g/l, mean (SD) | 39.0 (4.6) | 39.0 (4.4) | 39.5 (4.4) | 38.5 (5.0) | 0.14 |
eGFR, ml/min/1.73 m2, mean (SD) | 73.9 (28.1) | 77.1 (25.4) | 77.0 (27.2) | 67.6 (30.5) | 0.003 |
Infection, n (%) | 93 (19.1) | 23 (14.2) | 25 (15.4) | 45 (27.6) | 0.003 |
Pain, n (%) | 257 (52.8) | 78 (48.1) | 93 (57.4) | 86 (52.8) | 0.25 |
Anemia, n (%) | 133 (27.3) | 37 (22.8) | 40 (24.7) | 56 (34.4) | 0.04 |
Vision impairment, n (%) | 168 (34.5) | 48 (29.6) | 59 (36.4) | 61 (37.4) | 0.28 |
Hearing impairment, n (%) | 164 (33.7) | 52 (32.1) | 56 (34.6) | 56 (34.4) | 0.87 |
Cognitive impairment, n (%) | 137 (28.1) | 40 (24.7) | 34 (21.0) | 63 (38.7) | 0.001 |
ADL, median (IQR) | 85 (60-95) | 90 (60-100) | 90 (64-100) | 75 (45-95) | <0.001 |
CCI, median (IQR) | 1 (1-2) | 1 (0-2) | 1 (1-2) | 1 (1-3) | 0.10 |
Statin treatment after admission, n (%) | 234 (48.0) | 81 (50.0) | 87 (53.7) | 66 (40.5) | 0.05 |
Hospitalization days, median (IQR) | 18 (13-26) | 17 (12-24) | 18 (13-24) | 18 (12-28) | 0.38 |